Mehdi Najafzadeh

Brigham and Women's Hospital, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• Predicting Treatment Effects of a New Drug in a Target Population Based on Randomized Controlled Trial Results

  Friday, August 26, 2022
  2:30 PM – 2:45 PM CEST

• Effectiveness and Safety of Empagliflozin in Routine Care: Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study

  Friday, August 26, 2022
  6:15 PM – 6:20 PM CEST

• Cardiovascular Effectiveness of Empagliflozin vs. Glucagon-like peptide-1 Receptor Agonists or Liraglutide in the EMPRISE Study

  Sunday, August 28, 2022
  9:30 AM – 9:45 AM CEST